Skip to main content
Indian Journal of Urology : IJU : Journal of the Urological Society of India logoLink to Indian Journal of Urology : IJU : Journal of the Urological Society of India
. 2019 Apr-Jun;35(2):175. doi: 10.4103/0970-1591.257220

Erratum: A game changing LATITUDE: Role of abiraterone plus prednisolone in metastatic hormonesensitive prostate cancer

PMCID: PMC6458818  PMID: 31000930

The title of the article “A game changing LATITUDE: Role of abiraterone plus prednisolone in metastatic hormonesensitive prostate cancer”, which appeared in the pages 333-334, issue 4, vol. 33 of Indian Journal of Urology,[1] is written incorrectly, and the correct title of the article should be read as “A game changing LATITUDE: Role of abiraterone plus prednisone in metastatic hormonesensitive prostate cancer”

The sentence under the heading 'Summary' is also written incorrectly as “The authors attributed it to the use of lower dose of prednisolone (5 mg) as compared to the conventionally used dosage (10 mg) and longer duration of abiraterone therapy.” instead the correct sentence is “The authors attributed it to the use of lower dose of prednisone (5 mg) as compared to the conventionally used dosage (10 mg) and longer duration of abiraterone therapy”.

The “How to cite this article” section should be read correctly as: Sharma AP. A game changing LATITUDE: Role of abiraterone plus prednisone in metastatic hormonesensitive prostate cancer. Indian J Urol 2017;33:333-4.

REFERENCE

  • 1.Sharma AP. A game changing LATITUDE: Role of abiraterone plus prednisolone in metastatic hormonesensitive prostate cancer. Indian J Urol. 2017;33:333–4. doi: 10.4103/iju.IJU_250_17. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Journal of Urology : IJU : Journal of the Urological Society of India are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES